The effects of ICS 205-930, A 5-HT antagonist, on arrhythmias and catecholamine release during canine myocardial ischaemia and reperfusion

Susan J. Coker, Harvey G. Dean, Kathleen A. Kane, J. Parratt

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The effects of ICS 205-930 ((3 α-tropanyl)-1H-indole-3-carboxylic acid ester), an antagonist of 5-HT at neuronal M receptors, were examined in anaesthetised greyhounds subject to acute coronary artery occlusion and reperfusion. Intravenous administration of 0.3 or 2.0 mg kg-1 of ICS 205-930 did not significantly alter haemodynamics or blood gases. The higher dose had marked antiarrhythmic activity. The total number of ischaemia-induced extrasystoles was reduced to 167 ± 64 compared with 467 ± 99 in controls. Ventricular fibrillation induced by reperfusion after 40 min of ischaemia was also significantly reduced from 80 to 33%. Immediately following release of the coronary artery occlusion significant increases in plasma noradrenaline and dopamine concentrations were detected in local coronary venous blood draining from the ischaemic area in control dogs. This catecholamine release was also evident in the dogs which received 2 mg kg-1 ICS 205-930 but was less marked. Thus the antiarrhythmic activity of ICS 205-930 may be related to antagonism of detrimental effects of 5-HT, such as the ability to facilitate the release of noradrenaline from sympathetic nerve terminals in the heart, although other mechanisms may be involved.

Original languageEnglish
Pages (from-to)211-218
Number of pages8
JournalEuropean Journal of Pharmacology
Volume127
Issue number3
DOIs
Publication statusPublished - Aug 15 1986

Fingerprint

tropisetron
Myocardial Reperfusion
Serotonin Antagonists
Catecholamines
Myocardial Ischemia
Canidae
Cardiac Arrhythmias
Coronary Occlusion
Coronary Vessels
Norepinephrine
Ischemia
Dogs
Premature Cardiac Complexes
Ventricular Fibrillation
Intravenous Administration
Reperfusion
Dopamine
Serotonin
Esters
Gases

Keywords

  • 5-HT antagonist
  • Arrhythmias
  • Catecholamines
  • ICS 205-930
  • Myocardial ischaemia
  • Reperfusion

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

The effects of ICS 205-930, A 5-HT antagonist, on arrhythmias and catecholamine release during canine myocardial ischaemia and reperfusion. / Coker, Susan J.; Dean, Harvey G.; Kane, Kathleen A.; Parratt, J.

In: European Journal of Pharmacology, Vol. 127, No. 3, 15.08.1986, p. 211-218.

Research output: Contribution to journalArticle

@article{6b373880991a48ff9a0d0dd702bb4ca0,
title = "The effects of ICS 205-930, A 5-HT antagonist, on arrhythmias and catecholamine release during canine myocardial ischaemia and reperfusion",
abstract = "The effects of ICS 205-930 ((3 α-tropanyl)-1H-indole-3-carboxylic acid ester), an antagonist of 5-HT at neuronal M receptors, were examined in anaesthetised greyhounds subject to acute coronary artery occlusion and reperfusion. Intravenous administration of 0.3 or 2.0 mg kg-1 of ICS 205-930 did not significantly alter haemodynamics or blood gases. The higher dose had marked antiarrhythmic activity. The total number of ischaemia-induced extrasystoles was reduced to 167 ± 64 compared with 467 ± 99 in controls. Ventricular fibrillation induced by reperfusion after 40 min of ischaemia was also significantly reduced from 80 to 33{\%}. Immediately following release of the coronary artery occlusion significant increases in plasma noradrenaline and dopamine concentrations were detected in local coronary venous blood draining from the ischaemic area in control dogs. This catecholamine release was also evident in the dogs which received 2 mg kg-1 ICS 205-930 but was less marked. Thus the antiarrhythmic activity of ICS 205-930 may be related to antagonism of detrimental effects of 5-HT, such as the ability to facilitate the release of noradrenaline from sympathetic nerve terminals in the heart, although other mechanisms may be involved.",
keywords = "5-HT antagonist, Arrhythmias, Catecholamines, ICS 205-930, Myocardial ischaemia, Reperfusion",
author = "Coker, {Susan J.} and Dean, {Harvey G.} and Kane, {Kathleen A.} and J. Parratt",
year = "1986",
month = "8",
day = "15",
doi = "10.1016/0014-2999(86)90366-3",
language = "English",
volume = "127",
pages = "211--218",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - The effects of ICS 205-930, A 5-HT antagonist, on arrhythmias and catecholamine release during canine myocardial ischaemia and reperfusion

AU - Coker, Susan J.

AU - Dean, Harvey G.

AU - Kane, Kathleen A.

AU - Parratt, J.

PY - 1986/8/15

Y1 - 1986/8/15

N2 - The effects of ICS 205-930 ((3 α-tropanyl)-1H-indole-3-carboxylic acid ester), an antagonist of 5-HT at neuronal M receptors, were examined in anaesthetised greyhounds subject to acute coronary artery occlusion and reperfusion. Intravenous administration of 0.3 or 2.0 mg kg-1 of ICS 205-930 did not significantly alter haemodynamics or blood gases. The higher dose had marked antiarrhythmic activity. The total number of ischaemia-induced extrasystoles was reduced to 167 ± 64 compared with 467 ± 99 in controls. Ventricular fibrillation induced by reperfusion after 40 min of ischaemia was also significantly reduced from 80 to 33%. Immediately following release of the coronary artery occlusion significant increases in plasma noradrenaline and dopamine concentrations were detected in local coronary venous blood draining from the ischaemic area in control dogs. This catecholamine release was also evident in the dogs which received 2 mg kg-1 ICS 205-930 but was less marked. Thus the antiarrhythmic activity of ICS 205-930 may be related to antagonism of detrimental effects of 5-HT, such as the ability to facilitate the release of noradrenaline from sympathetic nerve terminals in the heart, although other mechanisms may be involved.

AB - The effects of ICS 205-930 ((3 α-tropanyl)-1H-indole-3-carboxylic acid ester), an antagonist of 5-HT at neuronal M receptors, were examined in anaesthetised greyhounds subject to acute coronary artery occlusion and reperfusion. Intravenous administration of 0.3 or 2.0 mg kg-1 of ICS 205-930 did not significantly alter haemodynamics or blood gases. The higher dose had marked antiarrhythmic activity. The total number of ischaemia-induced extrasystoles was reduced to 167 ± 64 compared with 467 ± 99 in controls. Ventricular fibrillation induced by reperfusion after 40 min of ischaemia was also significantly reduced from 80 to 33%. Immediately following release of the coronary artery occlusion significant increases in plasma noradrenaline and dopamine concentrations were detected in local coronary venous blood draining from the ischaemic area in control dogs. This catecholamine release was also evident in the dogs which received 2 mg kg-1 ICS 205-930 but was less marked. Thus the antiarrhythmic activity of ICS 205-930 may be related to antagonism of detrimental effects of 5-HT, such as the ability to facilitate the release of noradrenaline from sympathetic nerve terminals in the heart, although other mechanisms may be involved.

KW - 5-HT antagonist

KW - Arrhythmias

KW - Catecholamines

KW - ICS 205-930

KW - Myocardial ischaemia

KW - Reperfusion

UR - http://www.scopus.com/inward/record.url?scp=0022521869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022521869&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(86)90366-3

DO - 10.1016/0014-2999(86)90366-3

M3 - Article

VL - 127

SP - 211

EP - 218

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 3

ER -